Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Research Article Volume 7 Issue 6

In-vitro and In-silico Studies on the Anti-inflammatory Properties of Arecoline from Areca catechu L. Nut

Ajesh Kumar A*, Syed Abuthahir SS and Syed Ali Padusha M

Department of Chemistry, Jamal Mohamed College (Autonomous), Affiliated to Bharathidasan University, Tiruchirappalli, Tamil Nadu, India

*Corresponding Author: Syed Abuthahir SS, Department of Chemistry, Jamal Mohamed College (Autonomous), Affiliated to Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.

Received: April 18, 2023; Published: May 08, 2023

Abstract

The development of anti-inflammatory medications that target NF-κB has received a lot of attention because NF-κB activation is also strongly linked to inflammatory illnesses. Therefore, the goal of the current study is to examine the anti-inflammatory properties of Areca catechu L. nut extract. The stability of the red blood cell membrane, in silico analysis, and in vitro denaturation of albumin were all investigated. An anti-inflammatory impact on albumin denaturation inhibition and HRBC membrane stability at 1000 g/mL, comparatively low IC50 value than normal, was seen in preliminary investigations utilising a single dose (10 mg/ml) of Areca catechu L. nut and its corresponding component arecoline. Arecoline's additional affinity for nuclear kappa factor B. These findings support the medical use of Areca catechu L. nut in inflammatory illnesses by demonstrating its anti-inflammatory.

 Keywords: In-vitro; In-silico; Anti-inflammatory; Arecoline; NF-κB; Albumin Denaturation Inhibition; HRBC

References

  1. Khan S., et al. “Studies on anti-inflammatory and analgesic activities of betel nut in rodents”. Journal of Ethnopharmacology 135 (2011): 654-661.
  2. Dharmadeva S., et al. “In vitro anti-inflammatory activity of Ficus racemosa bark using albumin denaturation method”. Journal of Ayu 39.4 (2018): 239-242.
  3. Ferrero-Miliani L., et al. “Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1β generation”. Clinical and Experimental Immunology 2 (2007): 227-235.
  4. Okoli CO., et al. “Anti-inflammatory activity of hexane leaf extract of Aspilia africanaD. Adams”. Journal of Ethnopharmacology 109.2 (2007): 219-222.
  5. Eming SA., et al. “Inflammation in wound repair. Molecular and cellular mechanisms”. Journal of Investigative Dermatology3 (2007): 514-525.
  6. Broz P and Monack DM. “Molecular mechanisms of inflammasome activation during microbial infections”. Immunology Review 243 (2011): 174-190.
  7. Hardmann Joel A., et al. “Pharmacological basis of therapeutics”. (1998): 1465.
  8. Walsh LJ. “Mast cells and oral inflammation”. Critical Reviews in Oral Biology and Medicine 14 (2003): 188-198.
  9. Clària J., et al. “New insights into the role of macrophages in adipose tissue inflammation and Fatty liver disease: modulation by endogenous omega-3 Fatty Acid-derived lipid mediators”. Frontiers in Immunology 2 (2011): 49.
  10. Park CM and Song YS. “Luteolin and luteolin-7-O-glucoside inhibit lipopolysaccharide-induced inflammatory responses through modulation of NF-κB/AP-1/PI3K-Akt signaling cascades in RAW 264.7 cells”. Nutrition Research and Practice 7 (2013): 423-429.
  11. Halici Z., et al. “Amiodarone has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced paw edema”. European Journal of Pharmacology 566 (2007): 215-221.
  12. Zamora R., et al. “Inducible nitric oxide synthase and inflammatory diseases”. Molecular Medicine 6 (2000): 347-373.
  13. Nostro A., et al. “Extraction methods and bioautography for evaluation of medicinal plant antimicrobial activity”. Letters in Applied Microbiology 30 (2000): 379-384.
  14. Maroon JC., et al. “Natural anti-inflammatory agents for pain relief”. Surgical Neurology International 1 (2010): 80.
  15. Chatterjee P., et al. “Evaluation of anti-inflammatory effects of green tea and black tea: A comparative in vitro study”. Journal of Advanced Pharmaceutical Technology and Research 2 (2012): 136-138.
  16. Tatti PN., et al. “Evaluation of in-vitro anti-denaturation activity of isolated compound of Buteamonosperma Bark”. Pharma Science Monitor4 (2012): 2314-2320.
  17. Dar SA., et al. “Bioassay guided isolation and identification of antiinflammatory and anti-microbial compounds from Urtadioica L. (Urticaceae) leaves”. African Journal of Biotechnology65 (2012): 12910-12920.
  18. Khuda, F., et al. “Evaluation of antiinflammatory activity of selected medicinal plants of Khyber Pakhtunkhwa, Pakistan”. Pakistan Journal of Pharmaceutical Sciences2 (2014): 365-368.
  19. Handa SS., et al. “Technologies for Medicinal and Aromatic Plants”. No. 66. 1st Italy: United Nations Industrial Development Organization and the International Centre for Science and High Technology (2008).
  20. Shenoy S., et al. “Evaluation of anti inflammatory activity of Tephrosia purpurea in rats”. Asian Pacific Journal of Tropical Medicine 3 (2010): 193-195.
  21. Ejebe DE., et al. “Analgesic and anti-inflammatory activities of the ethanol extract of the leaves of Helianthus Annus in Wistar rats”. Asian Pacific Journal of Tropical Medicine 5 (2010): 341-347.
  22. Sostres C., et al. “Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract”. Best Practice and Research Clinical Gastroenterology 24 (2010): 121-132.
  23. Tak PP and Firestein GS. “NF-κB: A key role in inflammatory diseases”. Journal of Clinical Investigation 107 (2001): 7-11.
  24. Ragab AE., et al. “In Vitro Characterization of Inhibitors for Lung A549 and Leukemia K562 Cell Lines from Fungal Transformation of Arecoline Supported by In Silico Docking to M3-mAChR and ADME Prediction”. Pharmaceuticals 15 (2022): 1171.

Citation

Citation: Ajesh Kumar A., et al.In-vitro and In-silico Studies on the Anti-inflammatory Properties of Arecoline from Areca catechu L. Nut". Acta Scientific Pharmaceutical Sciences 7.6 (2023): 03-08.

Copyright

Copyright: © 2023 Ajesh Kumar A., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US